Product Details for ANDA 062860
AMPICILLIN SODIUM (AMPICILLIN SODIUM)
EQ 125MG BASE/VIAL
Marketing Status: Discontinued
EQ 250MG BASE/VIAL
Marketing Status: Discontinued
EQ 500MG BASE/VIAL
Marketing Status: Discontinued
EQ 1GM BASE/VIAL
Marketing Status: Discontinued
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
EQ 125MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AMPICILLIN SODIUM
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 125MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 001
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
AMPICILLIN SODIUM (AMPICILLIN SODIUM)
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 125MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 001
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 250MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AMPICILLIN SODIUM
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 250MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 002
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
AMPICILLIN SODIUM (AMPICILLIN SODIUM)
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 250MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 002
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 500MG BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AMPICILLIN SODIUM
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 003
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
AMPICILLIN SODIUM (AMPICILLIN SODIUM)
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 003
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 1GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AMPICILLIN SODIUM
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 004
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
AMPICILLIN SODIUM (AMPICILLIN SODIUM)
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 004
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 2GM BASE/VIAL
Marketing Status: Discontinued
Active Ingredient: AMPICILLIN SODIUM
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 005
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: AMPICILLIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062860
Product Number: 005
Approval Date: Feb 5, 1988
Applicant Holder Full Name: APOTHECON INC DIV BRISTOL MYERS SQUIBB
Marketing Status: Discontinued
Patent and Exclusivity Information